Home/Filings/4/0001655759-25-000087
4//SEC Filing

Berkowitz Noah 4

Accession 0001655759-25-000087

CIK 0001655759other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 5:15 PM ET

Size

7.7 KB

Accession

0001655759-25-000087

Insider Transaction Report

Form 4
Period: 2025-05-09
Berkowitz Noah
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2025-05-09+59,600169,623 total
  • Award

    Stock Option (right to buy)

    2025-05-09+91,00091,000 total
    Exercise: $6.61Exp: 2035-05-08Common Stock (91,000 underlying)
Footnotes (2)
  • [F1]The restricted stock units (each, an "RSU") were granted by the issuer on May 9, 2025, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
  • [F2]The option was granted by the Issuer on May 9, 2025, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.

Issuer

ARVINAS, INC.

CIK 0001655759

Entity typeother

Related Parties

1
  • filerCIK 0001369900

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:15 PM ET
Size
7.7 KB